Audentes Therapeutics, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | −$26.4M | −$18.2M | −$10.5M | −$26.7M |
| Net income | −$25.6M | −$18.1M | −$10.5M | −$26.5M |
| Total assets | $472.6M | $178.7M | $142.1M | $117.5M |
| Total liabilities | $29.8M | $22.1M | $22.7M | $15.8M |
| Equity | $442.8M | $156.6M | $119.4M | $101.7M |
| EPS (diluted) | — | — | — | — |
| Shares out. | 36.7M | 21.9M | 21.7M | 2.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- —
- Net margin
- —
- Return on equity
- −5.8%
- Return on assets
- −5.4%
- Return on capital (ROCE)
- −5.9%
- Liabilities / assets
- 6.3%
- Debt / equity
- 0.07×
- Book value / share
- $12.07
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- 18.52safe
- Accruals / assets
- 17.4%high accruals
- Piotroski F-Score
- 3/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 warning● 2 good- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Holles Natalie C.Officer — President and COO | Jan 15, 2020 | U | 104,439 | $60.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventJan 15, 2020
- Director / officer changeDec 16, 2019
- Entered a material agreement · Director / officer change · Other material eventDec 3, 2019
- Results of operationsNov 7, 2019
- Other material eventOct 9, 2019
- Results of operationsAug 6, 2019
- Director / officer changeJun 28, 2019
- Director / officer change · Shareholder voteJun 7, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 3FORM 3 SUBMISSIONOct 31, 2022
- SC 13DOct 31, 2022
- SC 13G/AFeb 14, 2020
- SC 13G/AFeb 14, 2020
- SC 13G/AFeb 14, 2020
- SC 13GSCHEDULE 13GFeb 11, 2020
- SC 13G/AFeb 5, 2020
- 15-12BJan 27, 2020
- EFFECTJan 17, 2020
- EFFECTJan 17, 2020
- 4FORM 4 SUBMISSIONJan 15, 2020
- 4FORM 4 SUBMISSIONJan 15, 2020
- 4FORM 4 SUBMISSIONJan 15, 2020
- 4FORM 4 SUBMISSIONJan 15, 2020
- 4FORM 4 SUBMISSIONJan 15, 2020
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.